NFE2L2 and neoplasm: On the other hand, Singh et al. demonstrated that deletion of Keap1 locus (19p13.2) recurrently occurred in NSCLC, which might increase the nuclear accumulation of Nrf2 and reduce tumor’s sensitivity to chemotherapy [32].